Quick answer
Dr. Priya Sharma is a Asia Clinical Research Editor for Asia-Pacific Region pharmaceutical intelligence editor on NovaPharmaNews, with 56 published articles covering NMPA regulatory actions, clinical development, and market-moving news. Dr. Sharma reports on clinical trials and drug development across India, China, and Southeast Asia.
About Dr. Priya Sharma
Dr. Sharma reports on clinical trials and drug development across India, China, and Southeast Asia.
Coverage focus
Topics and beats Dr. covers across Asia-Pacific Region.
Explore related intelligence
Entity directories linked from this author's coverage.
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways
Articles by Dr. Priya Sharma
PDA Manufacturing APAC: Key Highlights and Takeaways
The PDA Pharmaceutical Manufacturing conference in the Asia-Pacific region highlights critical trends reshaping pharmaceutical production, including digital transformation, continuous manufacturing adoption, and supply chain resilience strategies.
PDA APAC: Manufacturing Innovations Day 1 Roundup
PDA APAC Pharmaceutical Manufacturing Day 1 highlighted manufacturing innovations, regulatory harmonization challenges, and the critical role of advanced technologies in reshaping APAC pharmaceutical production. Expert panels emphasized supply chain resilience, workforce development, and the imperative for manufacturers to adopt continuous manufacturing and quality-by-design principles.
PDA APAC: Pharma Manufacturing Insights - Day 1 Roundup
The PDA APAC Pharmaceutical Manufacturing conference convened industry leaders on Day 1 to discuss aseptic processing innovations, continuous manufacturing adoption barriers, and regulatory compliance strategies across diverse Asia-Pacific markets.
PDA APAC: Top Manufacturing Innovations Day 1
The Parenteral Drug Association's APAC Pharmaceutical Manufacturing Conference Day 1 highlighted critical innovations in aseptic processing, continuous manufacturing adoption, and regulatory harmonization reshaping sterile drug production across Asia-Pacific markets.
PDA APAC Manufacturing: Key Takeaways Day 1
The PDA APAC Pharmaceutical Manufacturing conference convened industry leaders to address aseptic processing innovations, continuous manufacturing adoption, and regulatory harmonization challenges shaping the Asia-Pacific pharmaceutical landscape.
APAC Clinical Event: Key Trends & Pharma Insights to Watch
The 17th Annual Clinical event in APAC convenes clinical research professionals and pharmaceutical stakeholders to discuss innovative trial designs, regulatory updates, and patient engagement strategies shaping drug development across Asia-Pacific markets.
Cryoport Q1 2026 Results: Revenue Jumps 26% Supporting Record 766 Clinical Trials and 21 Commercial Cell Gene Therapies
Cryoport reports 26% revenue growth in Q1 2026, supporting a record 766 global clinical trials and 21 commercially approved cell and gene therapies worldwide.
Mifepristone Access Continues Under Supreme Court Hold as Planned Parenthood Responds to 5th Circuit Ruling
Planned Parenthood can continue dispensing Mifepristone by mail and certified pharmacies until May 11 following Supreme Court provisional hold on 5th Circuit ruling.
Arrowhead Pharmaceuticals Receives TGA Approval for REDEMPLO (Plozasiran) in Australia for Rare Genetic Disorder
Arrowhead Pharmaceuticals gains Australian TGA approval for REDEMPLO (plozasiran), expanding global access for familial chylomicronemia syndrome patients.
Amgen Reports Strong Q1 2026 Financial Results with 16 Brands Achieving Double-Digit Growth
Amgen's Q1 2026 results show robust performance with 16 brands posting double-digit growth, offsetting patent expirations and increased competition.
Haier Biomedical Reports Record 36% International Revenue Growth in Life Science Infrastructure Market
Haier Biomedical achieves 36% international revenue share with $340.77M total revenue, driving AI-powered life science infrastructure expansion globally.
Prolacta's Human Milk-Based Fortifiers Receive World's First Prescription Drug Status in Japan Following JASMINE Trial Success
Prolacta achieves global regulatory milestone as Japan grants prescription drug status to human milk-based fortifiers for premature infants based on JASMINE trial data.
Vivacta Bio Raises $50M+ Series A Funding for GT801 CAR-T Gene Therapy Development
Vivacta Biotechnology closes $50M+ Series A funding to advance GT801, an innovative in vivo CAR-T therapy for blood cancers and autoimmune diseases.
Energenesis Biomedical ENERGI-F703DFU Diabetic Foot Ulcer Treatment Data to Be Presented at EWMA 2026
Energenesis Biomedical will present clinical data for ENERGI-F703DFU gel, a novel topical treatment for diabetic foot ulcers, at EWMA 2026 in Bremen.
KRAS G12C Inhibitors NSCLC: Market Analysis of Sotorasib & Adagrasib
This article delves into the market dynamics of KRAS G12C inhibitors, Sotorasib and Adagrasib, highlighting their roles in non-small cell lung cancer treatment.
Thailand Emerges as ASEAN Medical Device Gateway as Market Set to Reach $18.6B by 2029
Thailand positions itself as Southeast Asia's medical device hub with WHX Bangkok 2026, targeting $18.6B regional MedTech market growing at 7.31% annually.
SAHPRA Biosimilars Approval: Pathway Analysis & Access Impact
This article analyzes SAHPRA's biosimilars approval pathway and its significant impact on improving access to vital treatments, including adalimumab.
Patient Diversity in MEA Clinical Trials: Strategies for Inclusive Recruitment
This article discusses the importance of patient diversity in MEA clinical trials and outlines strategies to enhance inclusive recruitment for better drug efficacy.
Zhengye Biotechnology Reports Fiscal 2025 Financial Results for Veterinary Vaccine Business
Zhengye Biotechnology (NASDAQ: ZYBT) announces fiscal year 2025 financial results, highlighting performance in veterinary vaccine manufacturing and research operations.
Testosterone Therapy FDA Update: Key Regulatory Advances
The FDA has announced important regulatory advancements on testosterone therapy for men, focusing on improved safety monitoring and updated approval processes. Learn what this means for testosterone deficiency treatment.
Eyebright Medical Reports Strong 2025 Results Driven by Innovation and Global Expansion
Eyebright Medical Technology releases 2025 annual and sustainability reports showing strong performance amid industry policy adjustments and global expansion.
Transcarent Partners with SmithRx to Expand Pharmacy Benefits Platform for Lower Drug Costs
Transcarent integrates SmithRx into its WayFinding platform to provide employers with enhanced pharmacy pricing transparency and reduced prescription drug costs.
HanchorBio Partners with Bloomberg to Enhance Drug Development Intelligence and Biopharma Strategy
HanchorBio selects Bloomberg's strategic intelligence platform to strengthen its immunotherapy drug development and global biopharma operations.
ANVISA Approves Emtricitabine-Tenofovir Combo: Market Impact in Brazil
The recent ANVISA approval of the Emtricitabine-Tenofovir combination for HIV treatment is set to transform the Brazilian pharmaceutical market.
Frequently asked questions
Who writes NovaPharmaNews articles?
Each story is attributed to a named editor or analyst with a public author profile. Profiles list credentials, coverage focus, and every published article so readers and AI systems can verify expertise and trace claims to a accountable journalist.
How do I find more coverage from this author?
Scroll to the article archive on this page, or use the topic chips linked from the author’s specializations. The regional authors directory lists every active contributor in this edition.
How does author coverage connect to companies and pipeline data?
Articles link to company profiles, drug INN pages, clinical trials, and pipeline programs when entities are tagged. Use the intelligence spokes on each story or browse topic hubs from the author’s beat.